← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 26, 2018Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 1, 2016
Cartesian Therapeutics— Founded
2020s
- Nov 13, 2023
Selecta Biosciences, Inc.— Acquired
Drugs by trial phase (16 distinct, 20 trials)
Phase 3 (1 own, 1 via acquisition)
Phase 2 (3 own, 4 via acquisition)
Phase 1 (4 own, 3 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (12)
- NCT07089121Lead sponsorPhase 1/Phase 2Dec 31, 2025
- NCT06799247Lead sponsorPhase 3May 6, 2025
- NCT06304636Lead sponsorPhase 1Jun 19, 2024
- NCT06038474Lead sponsorPhase 2Nov 1, 2023
- NCT05113342Lead sponsorPhase 1/Phase 2Nov 30, 2021
- NCT04816526Lead sponsorPhase 2Oct 31, 2021
- NCT04524962Lead sponsorPhase 1/Phase 2Sep 15, 2020
- NCT04436029Lead sponsorPhase 2Jun 12, 2020
- NCT04146051Lead sponsorPhase 1/Phase 2Nov 1, 2019
- NCT03994705Lead sponsorPhase 1Jul 31, 2019
- NCT03448978Study directorPhase 1Feb 26, 2018
- NCT03448978Lead sponsorPhase 1Feb 26, 2018
Details
- Founded
- Rockville, MD, US Jun 1, 2016
- Last known activity
- Dec 31, 2025